Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | UGT1A1 | P22309 | 1/20 | 1.00 |
| ▸ | SQLE | Q14534 | 7/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | ICMT | O60725 | 1/20 | 0.57 |
| ▸ | FNTA | P49354 | 1/20 | 0.53 |
| ▸ | FNTB | P49356 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Geranylgeraniol SCHEMBL127330 | 1.00 | KMT2A (1.00) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL7944378 | 1.00 | KMT2A (1.00) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| Farnesol SCHEMBL17633996 | 1.00 | KMT2A (1.00) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| Geranylgeraniol SCHEMBL17557239 | 1.00 | KMT2A (1.00) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| Geranylgeraniol SCHEMBL16664300 | 1.00 | KMT2A (1.00) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL4717874 | 1.00 | KMT2A (1.00) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| Geranylgeraniol SCHEMBL23814969 | 1.00 | KMT2A (1.00) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| Solanesol SCHEMBL4762223 | 1.00 | KMT2A (1.00) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| Farnesol SCHEMBL7546574 | 1.00 | KMT2A (1.00) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL16664315 | 1.00 | KMT2A (1.00) | KMT2AMAPTMEN1CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0731160-B1 | Parfume containing (3S)-(6E)-2,3-dihydrofarnesol | TAKASAGO PERFUMERY CO LTD (JP) | 2002-06-12 | — | — | EP | claimed |
| US-5753610-A | MICROBIOCIDE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1998-05-19 | — | — | US | claimed |
| EP-0731160-A2 | Perfume containing (6E)-2,3-dihydrofarnesol | Takasago International Corporation (JP) | 1996-09-11 | — | — | EP | claimed |
| JP-8245979-A | — | — | None | — | — | JP | disclosed |
| US-20240209132-A1 | COUPLING OF 2,3,5-TRIMETHYLHYDROQUINONE AND UNSATURATED ALCOHOLS | DSM IP ASSETS B.V. (NL) | 2024-06-27 | — | — | US | disclosed |
| EP-4330244-A1 | COUPLING OF 2,3,5-TRIMETHYLHYDROQUINONE AND UNSATURATED ALCOHOLS | DSM IP Assets B.V. (NL) | 2024-03-06 | — | — | EP | disclosed |
| CN-117203193-A | Coupling of 2,3, 5-trimethylhydroquinone with unsaturated alcohols | 帝斯曼知识产权资产管理有限公司 | 2023-12-08 | — | — | CN | disclosed |
| US-11802100-B2 | Olefins and methods for making the same | Amyris, Inc. (US) | 2023-10-31 | — | — | US | disclosed |
| CN-109071480-A | Solid forms of (-) -ambrox formed by bioconversion of homofarnesol in the presence of a biocatalyst | 奇华顿股份有限公司 | 2018-12-21 | — | — | CN | disclosed |
| US-9862906-B2 | Base oils and methods for making the same | Amyris, Inc. (US) | 2018-01-09 | — | — | US | disclosed |
| US-9464257-B2 | Fragrance composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-10-11 | — | — | US | disclosed |
| US-5753610-A | MICROBIOCIDE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1998-05-19 | — | — | US | disclosed |
| US-5753610-A | MICROBIOCIDE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1998-05-19 | — | — | US | disclosed |
| EP-0731160-A3 | Perfume containing (6E)-2,3-dihydrofarnesol | TAKASAGO PERFUMERY CO LTD (JP) | 1997-04-16 | — | — | EP | disclosed |
| EP-0754028-A1 | NOVEL DEODORISING AND ANTI-MICROBIAL COMPOSITIONS FOR USE IN COSMETIC OR TOPICAL PREPARATIONS | Beiersdorf Aktiengesellschaft (DE) | 1997-01-22 | — | — | EP | disclosed |
| JP-H08245979-A | PERFUME CONTAINING (6E)-2,3-DIHYDROFARNESOL | TAKASAGO INTERNATL CORP | 1996-09-24 | — | — | JP | disclosed |
| EP-0731160-A2 | Perfume containing (6E)-2,3-dihydrofarnesol | Takasago International Corporation (JP) | 1996-09-11 | — | — | EP | disclosed |
| EP-0731160-A2 | Perfume containing (6E)-2,3-dihydrofarnesol | Takasago International Corporation (JP) | 1996-09-11 | — | — | EP | disclosed |
| EP-0731160-A2 | Perfume containing (6E)-2,3-dihydrofarnesol | Takasago International Corporation (JP) | 1996-09-11 | — | — | EP | disclosed |
| WO-1995026708-A2 | NOVEL DEODORISING AND ANTI-MICROBIAL COMPOSITIONS FOR USE IN COSMETIC OR TOPICAL PREPARATIONS | BEIERSDORF AG (DE) | 1995-10-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11802100-B2 | Olefins and methods for making the same | HSD17B10, DHCR7, HSD17B12 | KMT2A 2865/4885MAPT 3808/4885MEN1 2680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.